News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Avnur Zafrira
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 05/22/2020 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
|
|
| 05/29/2019 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
|
|
| 06/19/2018 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $23.27, valued at
$930.8k
|
|
| 03/28/2018 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 2,000 shares
@ $9.49, valued at
$19k
|
|
| 03/22/2018 |
4
| Avnur Zafrira (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 263 shares
@ $7.6, valued at
$2k
|
|
|
|